GSK set to complete $20 bln Novartis asset swap next week
February 25, 2015 at 11:42 AM EST
LONDON, Feb 25 (Reuters) - GlaxoSmithKline said on Wednesday it expected to conclude a $20 billion-plus three-part asset swap with Novartis in the week commencing March 2, following progress in obtaining clearances for the deal.
